Bio Protocol vs Orchid — how do they compare? Bio Protocol trades at Rp514.01 (market cap Rp1,16T, Rp252,63M 24h volume), while Orchid trades at Rp164.34 (market cap Rp190,2M, Rp47,84M 24h volume). The key difference: Bio Protocol is far larger — about 6098.8× Orchid's market cap, and Bio Protocol's supply is capped (2,2B / 3,3B BIO (68%)) while Orchid's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Orchid for 42 Days on average.
| BIO | OXT | |
|---|---|---|
Market Cap | Rp1,16T | Rp190,2M |
Volume (24h) | Rp252,63M | Rp47,84M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 997,2M OXT |
Typical Hold Time | 16 Days | 42 Days |
What Pluang investors did over the last 30 days
No sentiment data available yet.
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Orchid describes itself as the world’s first incentivized, peer-to-peer privacy network. Its aim is to overcome internet freedom limitations by using cryptocurrency payments to allow anyone to purchase bandwidth from any participating provider. This is done using so-called probabilistic nanopayments, which occur using OXT, an ERC-20 standard token on Ethereum.
Read more on OXT →